IAS News and Literature Updates:
October/November 2016
 From the President's Desk:
Yuji Matsuzawa

The IAS continues to mentor and support the future key opinion leaders in the field through a number of initiatives, especially support of early- and mid-career clinicians and researchers.
 
The IAS Visiting Fellowship Awards are presented each year in an effort to develop skills that will not only impact favourably on your personal career but will also enhance clinical and research programs in your home country. The deadline to submit your application for 2017 is fast approaching: January 31, 2017. Please visit our web site for more complete information (www.athero.org) but note that you will need confirmation from the host laboratory as part of your application. This program has been in effect since 1991 and has supported more than 85 international scientists working in laboratories around the world, many of whom have gone on to have a major impact on the field.


> Complete Article < 


APPLY NOW!!

IAS Visiting Fellowship Opportunities
Application Deadline: January 31, 2017
3 - Month Visiting Fellowship Award $5,000
• 6 - Month Visiting Fellowship Award $8,000
 

For more information click here

IAS Severe FH Panel 

IAS Consensus Statement “Defining severe familial hypercholesterolemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel”

The International Atherosclerosis Society (IAS) is proud to announce the publication on the definition of severe FH and the implications for clinical management in The Lancet Diabetes and Endocrinology. The IAS Severe FH Panel, made of 25 internationally renowned experts and chaired by Dr. Raul Santos, worked with the objective of characterizing the severe FH phenotype and made recommendations on how to stratify CVD risk and to whom to prescribe the novel lipid lowering treatments. These recommendations will contribute to improved daily clinical practice and better management of FH patients.

To download the full text, which is open access, please link to and register at the WEBLINK
 (Published online, May 27, 2016).
For more information about The Lancet, please visit The Lancet Homepage at www.thelancet.com.

Also included in this newsletter:

Toronto, Canada
June 9 - 12, 2018


XVIII International Symposium on Atherosclerosis

In the News: 
 
FEATURED COMMENTARIES: 

Circulating Soluble Low-Density Lipoprotein Receptor-Related Protein 1 (sLRP1) Concentration Is Associated with Hypercholesterolemia: A New Potential Biomarker for Atherosclerosis

By: Vicenta Llorente Cortes


Lipid accumulation in the vascular wall is a major problem in atherosclerosis. It has recently been shown that around 40% of foam cells, previously considered of macrophage origin, are of vascular smooth muscle cells (VSMC) origin, indicating that VSMC are crucial players in  vascular lipid accumulation. While the incorporation of lipids by macrophages leads to cell death, VSMC-foam cells are more resistant to apoptosis and they may reside in the vessels for years, causing a high impact on the process of vascular degeneration.

> View Complete Commentary <

Childhood Infections, Socio-economic Status, and Adult Cardiometabolic Risk

By: Richard S Liu, David P Burgner, Matthew A Sabin, Costan G Magnussen, Michael Cheung, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Eero Jokinen, Tomi Laitinen, Leena Taittonen, Terence Dwyer, Jorma SA Viikari, Mika Kivimäki, Olli T Raitakari, and Markus Juonala.


There is increasing evidence that childhood infections are associated with increased cardiometabolic risk and disease in later life. It is well-known that cardiometabolic disease shows strong social gradients, but mechanisms are poorly understood. Our recent paper in provides some evidence that childhood infection may lie on the causal pathway linking socioeconomic deprivation in early life and poor adult cardiometabolic health.

> View Complete Commentary <

UPCOMING MEETINGS:


November 30 - December 3, 2016

IAS-Chilean WG Session on News and Controversies in Diagnosis and Management of Dyslipidemias: From Theory to Clinical Practice, held during the SOCHICAR Congress
Puerto Varas, Chiles


View Meeting Website


February 27- March 1, 2018

Philippine Lipid and Atherosclerosis Society
The 11th APSAVD Congress (2018) Annual Scientific Meeting on Addressing Regional Diversity in Atherosclerosis
and Vascular Disease in the Asia-Pacific Region
Iloilo City, Philippines

View Meeting Information



For a complete listing of all Member Society meetings and educational activities.

Please Click Here

Acknowledgements

The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.

>> Back To Top <<
 
IAS Newsletter Editors
&
Website Editorial Board
 
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy
Emanuela Folco, PhD
Milan, Italy
Ann Jackson, MBA
Houston, TX, USA

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA

************************************************************************************************************************************************************

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129
Italy

Add us to your address book

Copyright (C) 2016 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile